PRDX2 and oral cavity squamous cell carcinoma: Though PRDX2 did not predict HNSCC prognosis, we still found that PRDX2 was positively associated with aggressive phenotype, such as angiogenesis, EMT, invasion, metastasis and proliferation, which was in line with oral squamous cell carcinoma (OSCC).